Family Connections vs Treatment at Usual Optimized in the treatment of relatives of people with eating disorders and personality disorders: Study protocol of a randomized control trial

Author:

Guillén Verónica1,Pérez Sandra1,Garcia-Alandete Joaquín1,Fernandez-Felipe Isabel2,Marco Jose Heliodoro3

Affiliation:

1. Universidad de Valencia

2. Universitat Jaume I Castellón

3. Instituto Salud Carlos III

Abstract

Abstract Background Family members of patients with eating disorders (ED) often experience high levels of burden, suffering, grief, and helplessness. If, in addition to ED, the patient has a personality disorder (PD), the psychological distress experienced by family members can be devastating. However, few treatments have been developed for family members of people with ED and PD. Family Connections (FC) is a program that has been shown to be effective in relatives of people with borderline personality disorder. The general objectives of this research project are: (a) to adapt and test the FC intervention protocol designed specifically for family members of patients with ED-PD in the Spanish population (FC: ED-PD); (b) to analyze, in a randomized controlled trial, the efficacy of the FC: ED-PD program versus a control condition consisting of optimized treatment as usual (TAU-O); (c) to analyze the feasibility and acceptability of the intervention protocol; (d) to analyze whether the changes that may occur in family members are related to improvements in the family climate and/or improvements observed in patients; and (e) to analyze the perceptions and opinions of families and patients about the two intervention protocols. Methods The study design consists of a two-arm randomized controlled trial with two conditions: FC: ED-PD or Treatment as usual optimized (TAU-O). Participants will be relatives of patients who meet DSM-5 criteria for ED and PD or dysfunctional personality traits. Participants will be assessed at pre- and post-treatment and one-year follow-up. The intention-to-treat principle will be used when analyzing the data. Discussion These results will also confirm the program’s efficacy and acceptance by family members. Trial registration ClinicalTrials.gov Identifier: NCT05404035. Accepted: May 2022.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3